Cross-border M&A originating from developing countries (The case of the Indian pharmaceutical industry). Issue 9 (12th September 2016)

• Record Type: Journal Article
• Authors: Amir-Aslani, Arsia; Chanel, Mark Anthony
• Is Part Of: Strategic direction. Volume 32:Issue 9(2016)
• Page Start: 19
• Page End: 21
• Publication Date: 2016-09-12
• Subjects: Developing countries -- Pharmaceutical -- Cross-border M%26A -- Drug discovery; Management -- Periodicals; 658.4005
• DOI: 10.1108/SD-05-2016-0062
• Languages: English
• ISSNs: 0258-0543

Abstract

Abstract : Purpose: The paper aims to highlight the growing use of M&A as a strategic tool by companies originating from the emerging markets. Findings: Cross-border mergers play an increasingly important role in the strategies of firms originating from developing countries in expanding their capabilities and expertise within the drug discovery value chain by providing world class service and international business knowledge. Originality/value: M&A literature is very extensive. However, there is need for more research focusing on M&A activity originating from emerging countries.